GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sandoz Group AG (OTCPK:SDZNY) » Definitions » Total Liabilities

Sandoz Group AG (Sandoz Group AG) Total Liabilities : $10,776 Mil (As of Dec. 2023)


View and export this data going back to 2023. Start your Free Trial

What is Sandoz Group AG Total Liabilities?

Sandoz Group AG's Total Liabilities for the quarter that ended in Dec. 2023 was $10,776 Mil.

Sandoz Group AG's quarterly Total Liabilities increased from . 20 ($0.00 Mil) to Dec. 2022 ($8,797.00 Mil) and increased from Dec. 2022 ($8,797.00 Mil) to Dec. 2023 ($10,776.00 Mil).

Sandoz Group AG's annual Total Liabilities increased from . 20 ($0.00 Mil) to Dec. 2022 ($8,797.00 Mil) and increased from Dec. 2022 ($8,797.00 Mil) to Dec. 2023 ($10,776.00 Mil).


Sandoz Group AG Total Liabilities Historical Data

The historical data trend for Sandoz Group AG's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sandoz Group AG Total Liabilities Chart

Sandoz Group AG Annual Data
Trend Dec22 Dec23
Total Liabilities
8,797.00 10,776.00

Sandoz Group AG Quarterly Data
Dec22 Dec23
Total Liabilities 8,797.00 10,776.00

Sandoz Group AG Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Sandoz Group AG's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=5698+(4230+588
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+0+260)
=10,776

Total Liabilities=Total Assets (A: Dec. 2023 )-Total Equity (A: Dec. 2023 )
=19430-8654
=10,776

Sandoz Group AG's Total Liabilities for the quarter that ended in Dec. 2023 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=5698+(4230+588
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+0+260)
=10,776

Total Liabilities=Total Assets (Q: Dec. 2023 )-Total Equity (Q: Dec. 2023 )
=19430-8654
=10,776

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sandoz Group AG Total Liabilities Related Terms

Thank you for viewing the detailed overview of Sandoz Group AG's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


Sandoz Group AG (Sandoz Group AG) Business Description

Traded in Other Exchanges
Address
Forum 1, Novartis Campus, Basel, CHE, CH-4056
Sandoz is one of the largest generic pharmaceutical manufacturers in the world, generating over $9 billion annually from off-patent drugs. Once part of Novartis, Sandoz spun off and went public in October 2023. Generics, including small molecules and complex injectables, make up roughly 75% of Sandoz's total sales, and the firm has a significant presence in Europe, the United States, and other key international markets. Sandoz generates its remaining sales from biosimilars and is among leaders in the space. Sandoz launched Europe's first biosimilar, Omnitrope, in 2006 as well as U.S.'s first biosimilar, Zarxio, in 2015. It currently has eight commercialized biosimilars in a number of markets and has over 20 assets in pipeline.

Sandoz Group AG (Sandoz Group AG) Headlines

From GuruFocus

Q3 2023 Sandoz Group AG Earnings Call Transcript

By GuruFocus Research 02-14-2024

Q3 2023 Sandoz Group AG Earnings Call Transcript

By GuruFocus Research 02-14-2024